Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Crystal Hervey"'
Publikováno v:
International Journal of Pediatrics, Vol 2012 (2012)
Fragile X syndrome (FXS) is associated with behavior that limits functioning, including distractibility, hyperactivity, impulsivity, hyperarousal, anxiety, mood dysregulation, and aggression. Medication response and side effect data were reviewed ret
Externí odkaz:
https://doaj.org/article/941aaebcd09c4b6fb73aca5db41c3720
Publikováno v:
Journal of Autism and Developmental Disorders
Journal of Autism and Developmental Disorders, vol 41, iss 11
Journal of autism and developmental disorders, vol 41, iss 11
Journal of Autism and Developmental Disorders, vol 41, iss 11
Journal of autism and developmental disorders, vol 41, iss 11
Recent insight into the underlying molecular and cellular mechanisms of fragile X syndrome (FXS) has led to the proposal and development of new pharmaceutical treatment strategies, and the initiation of clinical trials aimed at correcting core sympto
Autor:
Elizabeth Chruscinski, Randi J Hagerman, Jennifer Yuhas, David R Hessl, Lisa Cordeiro, Crystal Hervey, Elizabeth Berry-Kravis, Aaron Campbell, James M. Long, Edward M. Ornitz
Publikováno v:
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. :545-553
Pharmacological rescue of behavioral, cognitive and synaptic abnormalities in the animal models of fragile X syndrome (FXS) has prompted the initiation of clinical trials of targeted treatments in humans with this condition. Objective, well-validated
Autor:
Elizabeth Berry-Kravis, David R Hessl, Christina Tran, Andrea Schneider, Floridette Abucayan, Andrew Knox, Crystal Hervey
Publikováno v:
Journal of Neurodevelopmental Disorders
Journal of Neurodevelopmental Disorders, Vol 4, Iss 1, p 2 (2012)
Knox, Andrew; Schneider, Andrea; Abucayan, Floridette; Hervey, Crystal; Tran, Christina; Hessl, David; et al.(2012). Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS). Journal of Neurodevelopmental Disorders, 4(1), 2. doi: http://dx.doi.org/10.1186/1866-1955-4-2. Retrieved from: http://www.escholarship.org/uc/item/8sq796fq
Journal of Neurodevelopmental Disorders, Vol 4, Iss 1, p 2 (2012)
Knox, Andrew; Schneider, Andrea; Abucayan, Floridette; Hervey, Crystal; Tran, Christina; Hessl, David; et al.(2012). Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS). Journal of Neurodevelopmental Disorders, 4(1), 2. doi: http://dx.doi.org/10.1186/1866-1955-4-2. Retrieved from: http://www.escholarship.org/uc/item/8sq796fq
Background Attention and inhibition are core executive-function deficits in FRagile X syndrome (FXS). This pilot study evaluated the feasibility, reproducibility, and clinical relevance of the KiTAP, a computer-based pictorial measure of attention an
Publikováno v:
International Journal of Pediatrics
International Journal of Pediatrics, Vol 2012 (2012)
International Journal of Pediatrics, Vol 2012 (2012)
Fragile X syndrome (FXS) is associated with behavior that limits functioning, including distractibility, hyperactivity, impulsivity, hyperarousal, anxiety, mood dysregulation, and aggression. Medication response and side effect data were reviewed ret
Autor:
Elizabeth Berry-Kravis, Sara Abozeid, Crystal Hervey, M. Shahriar Salamat, Brian C. Ray, James S. Malter, Corinna Burger, Cara J. Westmark, Pamela R. Westmark, Kenneth J. O’Riordan, Kelsey M. Stein, Levi A. Stodola, Michael Tranfaglia
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 10, p e26549 (2011)
PLoS ONE, Vol 6, Iss 10, p e26549 (2011)
Fragile X syndrome (FXS) is the most common form of inherited intellectual disability and the leading known genetic cause of autism. Fragile X mental retardation protein (FMRP), which is absent or expressed at substantially reduced levels in FXS, bin
Publikováno v:
Journal of Alzheimer's Disease & Parkinsonism.
Altered levels of amyloid β-protein precursor (AβPP) and/or amyloid beta (Aβ) are characteristic of several neurological disorders including Alzheimer's disease (AD), Down syndrome (DS), Fragile X syndrome (FXS), Parkinson's disease (PD), autism a
Publikováno v:
Journal of Neurodevelopmental Disorders
Fragile X syndrome (FXS) is the most common identifiable genetic cause of intellectual disability and autistic spectrum disorders (ASD), with up to 50% of males and some females with FXS meeting criteria for ASD. Autistic features are present in a ve
Autor:
Randi J Hagerman, Crystal Hervey, Luis F. Campos, Kylee Cook, Jacky Au, Weerasak Chonchaiya, Danh V. Nguyen, Flora Tassone, Yi Mu, Elizabeth Berry-Kravis, Page L. Sorensen, L. Wang, K. Lohse, Agustini Utari, Louise W. Gane
Publikováno v:
Clinical genetics. 78(1)
Women with the fragile X mental retardation 1 (FMR1) premutation often have concerns about neurological and medical problems, as they become older and if their fathers experience fragile X-associated tremor/ataxia syndrome (FXTAS). We therefore deter
Autor:
Jennifer Yuhas, Randi J Hagerman, Danh V. Nguyen, Andrea Schneider, Crystal Hervey, Michael Tranfaglia, Elizabeth Berry-Kravis, Julie A Hutchison, David R Hessl, Michael Snape, Sarah M. Coffey
Publikováno v:
Journal of Medical Genetics
Berry-Kravis, E; Hessl, D; Coffey, S; Hervey, C; Schneider, A; Yuhas, J; et al.(2009). A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. Journal of Medical Genetics, 46(4), 266-271. doi: 10.1136/jmg.2008.063701. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/4n84s2qk
Berry-Kravis, E; Hessl, D; Coffey, S; Hervey, C; Schneider, A; Yuhas, J; et al.(2009). A pilot open label, single dose trial of fenobam in adults with fragile X syndrome. Journal of Medical Genetics, 46(4), 266-271. doi: 10.1136/jmg.2008.063701. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/4n84s2qk
Objective: A pilot open label, single dose trial of fenobam, an mGluR5 antagonist, was conducted to provide an initial evaluation of safety and pharmacokinetics in adult males and females with fragile X syndrome (FXS). Methods: Twelve subjects, recru